Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial. J of Skin. 2019;3:S9. doi:10.25251/skin.3.supp.9